Current Diabetes Reports

, Volume 9, Issue 5, pp 389–395 | Cite as

The usefulness of a Mediterranean-based diet in individuals with type 2 diabetes

Article

Abstract

This article reviews current data available on the Mediterranean diet related to its use in a diabetic population. Based on many published reports, it is apparent that the Mediterranean diet may be used in dietary interventions for the treatment of overweight and obesity, conditions associated with the development of type 2 diabetes. In addition, obesity in type 2 diabetic persons is associated with other cardiovascular disease risk factors. The Mediterranean diet has been found to be inversely related to the metabolic syndrome, often a feature of diabetic individuals. Perhaps the most critical information placing the Mediterranean diet in a favorable position is the positive response of insulin, blood glucose, blood lipids, and other metabolic factors predicting cardiovascular disease risk and outcomes. This diet is a viable treatment option; advisors should stress not only adherence to a fairly traditional Mediterranean eating plan but also a lifestyle that includes sufficient physical activity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Magkos F, Yannakoulia M, Chan JL, Mantzoros CS: Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Ann Rev Nutr 2009 Apr 27 (Epub ahead of print).Google Scholar
  2. 2.
    American Dietetic Association, American Diabetes Association: Choose Your Foods: Exchange Lists for Diabetes. Chicago, IL: American Dietetic Association; 2008.Google Scholar
  3. 3.
    Dansinger ML, Gleason JA, Griffith JL, et al.: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction. JAMA 2005, 293:43–53.PubMedCrossRefGoogle Scholar
  4. 4.
    Gardner CD, Kiazand A, Alhassan S, et al.: Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. The A to Z Weight Loss Study: a randomized trial. JAMA 2007, 297:969–977.PubMedCrossRefGoogle Scholar
  5. 5.
    Westman EC, Yancy WS, Mavropoulos JC, et al.: The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 2008, 5:36.CrossRefGoogle Scholar
  6. 6.
    Willett WC, Sacks F, Trichopoulou A, et al.: Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995, 61(Suppl):1402S–1406S.PubMedGoogle Scholar
  7. 7.
    Saura-Calixto F, Goñi I: Definition of the Mediterranean diet based on bioactive compounds. Crit Rev Food Sci Nutr 2009, 49:145–152.PubMedCrossRefGoogle Scholar
  8. 8.
    de Souza RJ, Swain JF, Appel LJ, Sacks FM: Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diet with popular diets and with dietary recommendations. Am J Clin Nutr 2008, 88:1–11.PubMedGoogle Scholar
  9. 9.
    Marinou K, Tousoulis D, Antonopoulos AS, et al.: Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol 2009 Apr 25 (Epub ahead of print).Google Scholar
  10. 10.
    International Diabetes Foundation: Fact sheet diabetes and cardiovascular disease (CVD). Available at http://www.idf.org/node/1191?node=1158. Accessed May 2009.
  11. 11.
    American Heart Association: Diabetes and cardiovascular disease. Available at http://www.americanheart.org/presenter.jhtml?identifier=3044762. Accessed May 2009.
  12. 12.
    Ratner RE, Maggs D, Nielsen LL, et al.: Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus. Diabetes Obes Metab 2006, 8:419–428.PubMedCrossRefGoogle Scholar
  13. 13.
    Riddle MC, Henry RR, Poon TH, et al.: Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin. Diabetes Metab Res Rev 2006, 22:483–491.PubMedCrossRefGoogle Scholar
  14. 14.
    Rosenstock J, Zinman B: Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2007, 14:98–107.PubMedGoogle Scholar
  15. 15.
    Sacks FM, Bray GA, Carey VJ, et al.: Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009, 360:859–873.PubMedCrossRefGoogle Scholar
  16. 16.
    Shai I, Schwarzfuchs D, Henkin Y, et al.: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008, 359:229–241.PubMedCrossRefGoogle Scholar
  17. 17.
    Buckland G, Bach A, Serra-Majem L: Obesity and the Mediterranean diet: a systematic review of observational and intervention studies. Obes Rev 2008, 9:582–593.PubMedCrossRefGoogle Scholar
  18. 18.
    International Diabetes Foundation: The IDF consensus worldwide definition of the metabolic syndrome. Available at http://www.idf.org/webdata/docs/MetS_def_update2006. pdf. Accessed May 2009.
  19. 19.
    Ford ES, Li C, Sattar N: Metabolic syndrome and incident diabetes. Diabetes Care 2008, 31:1898–1904.PubMedCrossRefGoogle Scholar
  20. 20.
    Ervin RB: Prevalence of Metabolic Syndrome Among Adults 20 Years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003–2006. National Health Statistics Reports; no 13. Hyattsville, MD: National Center for Health Statistics; 2009.Google Scholar
  21. 21.
    Ford ES, Li C, Zhao G, et al.: Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 2008, 31:587–589.PubMedCrossRefGoogle Scholar
  22. 22.
    Seguí-Gómez MS, de la Fuente C, Vázquez Z, et al.: Cohort profile: the ’seguimiento Universidad de Navarra’ (SUN) study. Int J Epidemiol 2006, 35:1417–1422.PubMedCrossRefGoogle Scholar
  23. 23.
    Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, et al.: Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007, 30:2957–2959.PubMedCrossRefGoogle Scholar
  24. 24.
    Panagiotakos DB, Pitsavos C, Chrysohoou C, et al.: Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004, 147:106–112.PubMedCrossRefGoogle Scholar
  25. 25.
    Mendez MA, Popkin BM, Jakszn P, et al.: Adherence to a Mediterranean diet is associated with reduced 3-year incidence of obesity. J Nutr 2006, 136:2934–2938.PubMedGoogle Scholar
  26. 26.
    Sanchez-Villegas A, Bes-Rastrollo M, Martinez-Gonzalez MA, Serra-Majem L: Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int J Obes 2006, 30:350–358.Google Scholar
  27. 27.
    Schroder H, Marrugat J, Vila J, et al.: Adherence to the traditional Mediterranean diet is inversely associated with body mass index and obesity in a Spanish population. J Nutr 2004, 134:3355–3361.PubMedGoogle Scholar
  28. 28.
    Esposito K, Marfella R, Ciotola M, et al.: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440–1446.PubMedCrossRefGoogle Scholar
  29. 29.
    Giugliano D, Ceriello A, Esposito K: Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Response to Tortosa et al. Diabetes Care 2008, 31:e36.PubMedCrossRefGoogle Scholar
  30. 30.
    Esposito K, Ceriello A, Giugliano D: Diet and the metabolic syndrome. Metab Syndr Relat Disord 2007, 5:291–296.PubMedCrossRefGoogle Scholar
  31. 31.
    Babio N, Bulló M, Basora J, et al.: Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovas Dis 2009 Jan 26 (Epub ahead of print).Google Scholar
  32. 32.
    Salas-Salvadó J, Fernández-Ballart J, Ros E, et al.: Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008, 168:2449–2258.PubMedCrossRefGoogle Scholar
  33. 33.
    Serra-Majem L: Efficacy of diets in weight loss regimens: is the Mediterranean diet appropriate? Pol Arch Med Wewn 2008, 118:691–693.PubMedGoogle Scholar
  34. 34.
    Muñoz MA, Fito M, Marrugat J, et al.: Adherence to the Mediterranean diet is associated with better mental and physical health. Br J Nutr 2008, 15:1–7.Google Scholar
  35. 35.
    Brunner EJ, Mosdøl, Witte DR, et al.: Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality. Am J Clin Nutr 2008, 87:1414–1421.PubMedGoogle Scholar
  36. 36.
    Esposito K, Giugliano D: Mediterranean dietary patterns and chronic diseases. Am J Clin Nutr 2008, 88:1179–1180.PubMedGoogle Scholar
  37. 37.
    Jenkins DJ, Kendall CW, McKeown-Eyssen G, et al.: Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes. JAMA 2008, 300:2742–2753.PubMedCrossRefGoogle Scholar
  38. 38.
    Martinez-González Má, de la Fuente-Arrillaga C, Nunez-Cordoba JM, et al.: Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. Br Med J 2008, 336:1348–1351.CrossRefGoogle Scholar
  39. 39.
    Panagiotakos DB, Tzima N, Pitsavos C, et al.: The association between adherence to the Mediterranean diet and fasting indices of glucose homeostasis: the ATTICA study. J Am Coll Nutr 2007, 26:32–38.PubMedGoogle Scholar
  40. 40.
    Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C: The epidemiology of type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med 2005, 22:1581–1588.PubMedCrossRefGoogle Scholar
  41. 41.
    Fraser A, Abel R, Lawlor DA, et al.: A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial. Diabetologia 2008, 51:1616–1622.PubMedCrossRefGoogle Scholar
  42. 42.
    Fraser A, Lawlor DA, Fraser D: Mediterranean diet in type 2 diabetes. Reply to Basterra-Gortari FJ, Martinez-González MA [letter]. Diabetologia 2008, 51:1935.CrossRefGoogle Scholar
  43. 43.
    Basterra-Gortari FJ, Martinez-González MA: Mediterranean diet in type 2 diabetes. Diabetologia 2008, 51:1933–1934.PubMedCrossRefGoogle Scholar
  44. 44.
    Mantzoros CS, Williams CJ, Manson JE, et al.: Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 2006, 84:328–355.PubMedGoogle Scholar
  45. 45.
    Giugliano D, Esposito K: Mediterranean diet and metabolic diseases. Curr Opin Lipidol 2008, 19:63–68.PubMedGoogle Scholar
  46. 46.
    Panagiotakos DB, Polystipioti A, Papairakleous N, Polychronopoulos E: Long-term adoption of a Mediterranean diet is associated with a better health status in elderly people; a cross-sectional survey in Cyprus. Asia Pac J Clin Nutr 2007, 16:331–337.PubMedGoogle Scholar
  47. 47.
    O’Keefe JH, Gheewala NM, O’Keefe JO: Dietary strategies for improving post-prandial glucose, lipids, inflam mation, and cardiovascular health. J Am Coll Cardiol 2008, 51:249–255.PubMedCrossRefGoogle Scholar
  48. 48.
    Laasko M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999, 48:937–942.CrossRefGoogle Scholar
  49. 49.
    Fung TT, Rexrode KM, Mantzoros CS, et al.: Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009, 119:1093–1100.PubMedCrossRefGoogle Scholar
  50. 50.
    USDA Food and Nutrient Database for Dietary Studies, 3.0. Beltsville, MD: Agricultural Research Service, Food Surveys Research Group; 2008.Google Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Pennington Biomedical Research CenterLouisiana State University SystemBaton RougeUSA

Personalised recommendations